Advertisement MerseyBIO selects Autonomy to support biotechnology network - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

MerseyBIO selects Autonomy to support biotechnology network

MerseyBIO, a biotechnology incubator organization, has implemented technology from infrastructure software provider Autonomy Corporation to power a network for the biotechnology community in Merseyside, England.

The service, called esymbio, aims to create an infrastructure that will foster collaboration between biotechnology companies, investors and public bodies to drive the development of the region’s life sciences sector by encouraging an active exchange of ideas, knowledge and experience.

The project is backed by public institutions such as the University of Liverpool and the North West Genetic Knowledge Park.

Autonomy said its technology is able to manage and locate all information stored in esymbio’s databases through a single front end, aiming to offer quick access to knowledge resources for the biotechnology community.

“The aim of esymbio is to provide a first meeting point for the industry, support the development of innovative products and create a prospering biotechnology sector,” said Geoff Wainwright, MerseyBIO incubator manager. “Autonomy will help us to achieve our goals by supporting the exchange of information and providing a comprehensive knowledge network for the community.”